1-(3,5,6-Trimethylpyridin-2-yl)piperazine → [4-(1,1-Dioxo-1lambda6-isothiazolidin-2-yl)-2-methoxyphenyl][4-(3,5,6-trimethylpyridin-2-yl)piperazin-1-yl]methanone
Reaction equation
[O:1]=[S:2]1(=[O:18])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[CH:14][C:10]([C:11]([OH:13])=O)=[C:9]([O:16][CH3:17])[CH:8]=1.[CH3:19][C:20]1[C:21]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[N:22][C:23]([CH3:27])=[C:24]([CH3:26])[CH:25]=1>>[O:18]=[S:2]1(=[O:1])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[CH:14][C:10]([C:11]([N:31]2[CH2:32][CH2:33][N:28]([C:21]3[C:20]([CH3:19])=[CH:25][C:24]([CH3:26])=[C:23]([CH3:27])[N:22]=3)[CH2:29][CH2:30]2)=[O:13])=[C:9]([O:16][CH3:17])[CH:8]=1Participants
3
Procedure
Using 4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methoxybenzoic acid (136 mg) described in Preparation Example 19 and 1-(3,5,6-trimethylpyridin-2-yl)piperazine (103 mg) described in Preparation Example 92 and by the reaction and treatment in the same manner as in Example 87, the title compound (138 mg) was obtained.
Workup
- customdescribed in Preparation Example 92 and by the reaction and treatment in the same manner as in Example 87
Sources & evidence
- ORD record
- ord-3f611d7487604d1a9e128d63fd6e77cc
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…